A narrative review of hybrid ablation for persistent and longstanding persistent atrial fibrillation
- PMID: 34350262
- PMCID: PMC8263859
- DOI: 10.21037/atm-21-196
A narrative review of hybrid ablation for persistent and longstanding persistent atrial fibrillation
Abstract
Atrial fibrillation is the most common sustained arrhythmia and is characterized by rapid and irregular atrial activation with loss of atrial contraction. There has been a significant evolution of treatments over the past 30 years. Initially, cardiac surgeons developed approaches via sternotomy with superior efficacy, however early iterations of the procedure were associated with prolonged recovery time and frequent need for pacemaker placement. The current surgical approach to the maze procedure via sternotomy yields excellent efficacy and is a Class 1 recommendation for patients with atrial fibrillation undergoing a concomitant procedure. Several years following the initial development of the surgical maze procedure, cardiac electrophysiologists developed less invasive, however less efficacious catheter ablation options by percutaneous approach. Both the surgical and transcatheter approaches have their advantages and disadvantages with varying risks of complications and efficacy. Through the combination of expertise of cardiac surgeons paired with the electrophysiology team, a hybrid ablation procedure has been developed offering an increased efficacy with a less-invasive approach than the current gold standard treatment of Cox-maze IV procedure. This review will discuss the hybrid ablation procedure, review recent associated clinical trials, and discuss advantages and challenges associated with this multidisciplinary approach for management of patients with AF.
Keywords: Atrial fibrillation; cardiac surgical procedures; electrophysiology.
2021 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at: http://dx.doi.org/10.21037/atm-21-196). AK serves as an unpaid editorial board member of Annals of Translational Medicine from May 2019 to Apr 2021. The authors have no other conflicts of interest to declare.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous